ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Turkey tail mushrooms tested as breast cancer treatment in new trial
Disease control Recruiting nowThis study tests whether turkey tail mushrooms can slow or shrink breast tumors in post-menopausal women with a common type of breast cancer (HER2-negative, ER-positive). About 40 women will take the mushroom supplement between diagnosis and surgery. The main goal is to see if th…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New radiation approach may delay need to switch cancer drugs in advanced breast cancer
Disease control Recruiting nowThis study tests whether a precise type of radiation (SBRT) can allow people with estrogen receptor-positive (ER+) breast cancer that has spread and is starting to grow again to keep using their current medication instead of switching to a new one. About 18 participants will rece…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Could a lower tamoxifen dose cut breast cancer risk? new trial seeks answers
Prevention Recruiting nowThis study tests whether a low dose of tamoxifen can safely reduce breast density—a key risk factor for breast cancer—in premenopausal women at higher-than-average risk. About 200 women will receive a response-guided dose, with adjustments based on how their breast density change…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 17, 2026 00:49 UTC
-
Ancient mushroom tested for cancer treatment side effects
Symptom relief Recruiting nowThis study tests whether Reishi mushroom extract can reduce fatigue and joint/muscle pain in breast cancer patients taking aromatase inhibitors. About 80 women with significant fatigue will take either the extract or a placebo for 8 weeks. The goal is to improve quality of life w…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 00:48 UTC
-
CBD extract tested to ease joint pain in breast cancer survivors
Symptom relief Recruiting nowThis study tests a high-CBD plant extract (BRC-001) to see if it can reduce joint pain and stiffness in women with breast cancer who take aromatase inhibitors (AIs). AIs lower estrogen to prevent cancer return but often cause arthritis-like side effects, leading some women to sto…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
New study aims to boost Self-Esteem in breast cancer survivors by improving skin health
Symptom relief Recruiting nowThis study looks at whether a skin care program can improve skin quality and self-esteem in breast cancer survivors who are starting a type of hormone therapy called aromatase inhibitors. The study will include 25 women with early-stage breast cancer. Researchers will use special…
Matched conditions: ESTROGEN RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC